Why the study?
Does cardiogenic shock at the acute stage of AMI increase long-term mortality in early survivors?
Population
3,411 early survivors of acute ST-elevation or non-ST-elevation myocardial infarction from the FAST-MI 2005…
Comparison
Presence of cardiogenic shock at the acute stage… vs Absence of cardiogenic shock at the acute stage…
Design
Cohort
Follow-up
5 years
Authors
Loading...
Cardiogenic shock in AMI survivors was associated with excess mortality only in the first year; leaves open whether targeted post-acute strategies improve outcomes.
Does cardiogenic shock at the acute stage of AMI increase long-term mortality in early survivors?
In patients surviving the early phase of acute myocardial infarction, cardiogenic shock at presentation increases mortality risk up to one year, but beyond one year, survival is similar to those without shock.
Aïssaoui et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: